Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;78(5):1135-42.
doi: 10.1111/bcp.12422.

Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies

Affiliations
Review

Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies

Ashwin Swaminathan et al. Br J Clin Pharmacol. 2014 Nov.

Abstract

Immunization with a T-cell dependent antigen has been promoted as a reliable and sensitive tool for assessing the influence of putative immunotoxic exposures or agents on immune function. Keyhole limpet haemocyanin (KLH) is a very large, copper-containing protein molecule derived from the haemolymph of the inedible mollusc, Megathura crenulata. KLH is a highly immunogenic T-cell dependent antigen that is used increasingly in immunotoxicological studies, particularly in those involving animals. This report systematically reviews the human clinical studies that have used trans-cutaneous KLH immunization for assessment of the influence of various physiological and disease states and exposures on immune function over the last 20 years (1994-2013). These studies varied in their immunization protocols, formulation of KLH, dose, site and route of administration and immunoassay platforms developed to assess KLH-specific responses. KLH immunization has been well tolerated with only mild to moderate adverse effects reported. Though very promising as a model antigen candidate in immunotoxicology research, more work on standardizing immunization and immunoassay protocols is required.

Keywords: KLH; clinical studies; immunization; immunotoxicology; keyhole limpet haemocyanin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. van Loveren H, Van Amsterdam JGC, Vandebriel RJ, Kimman TG, Rümke HC, Steerenberg PS, Vos JG. Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors review. Environ Health Perspect. 2001;109:757–764. - PMC - PubMed
    1. World Health Organisation. 2012. Harmonisation Project Document No.10: guidance for immunotoxicity risk assessment for chemicals. Geneva;
    1. Bugelski PJ, Kim C. T-dependent antigen response (TDAR) tests: meta-analysis of results generated across multiple laboratories. J Immunotoxicol. 2007;4:159–164. - PubMed
    1. Food and Drug Administration. 2006. S8 Immunotoxicity Studies for Human Pharmaceuticals. FDA.
    1. Sleijffers A, Garssen J, de Gruijl F, Boland G, van Hattum J, van Vloten W, van Loveren H. Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers. J Invest Dermatol. 2001;117:1144–1150. - PubMed

Publication types